Novo Nordisk owner to invest $200 million in quantum computing startups
By Martin Coulter LONDON (Reuters) - Novo Holdings, the controlling shareholder of Danish obesity drugmaker Novo Nordisk, said on Wednesday it plans to invest around $200 million in quantum computing startups. The company, the investment arm of the...
3h ago
GSK raises full-year profit forecast, says first-half will see stronger sales
(Reuters) -GSK raised its full-year profit forecast on Wednesday and said its sales would be higher in the first six months of the year than the second half on the back of strong demand for its common respiratory virus and shingles vaccines. The London...
3h ago
Stryker lifts 2024 profit forecast on strong demand for medical devices, implants
(Adds media packaging code) (Reuters) - Stryker Corp lifted its full-year profit forecast on Tuesday, owing to resilient demand for the company's medical devices and implants. The joint-implant maker now sees its annual profit per share to be betwe...
9h ago
Neurocrine Biosciences' Huntington's disease drug gets FDA approval
By Sruthi Narasimha Chari (Reuters) -The U.S. Food and Drug Administration (FDA) has approved the granule formulation of Neurocrine Biosciences' Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on Tu...
10h ago
Instant view: Biden administration plans to reclassify marijuana
(Reuters) - The U.S. Justice Department on Tuesday moved to make marijuana use a less serious federal crime, taking a step to reclassify the drug out of a category that includes heroin in a shift that, once completed, would shake up cannabis policy...
12h ago
First trial over Zantac cancer claims set to begin in Chicago
By Brendan Pierson (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago. Jury selection began on Tuesday before Judge Daniel Trevino...
12h ago
Almost all US hospitals took financial hit from Change hack, AHA says
By Amina Niasse NEW YORK (Reuters) - Almost all U.S. hospitals were hurt financially by the cyberattack on United Health Group's Change Healthcare unit earlier this year, according to a survey from the American Hospital Association (AHA). The AHA s...
12h ago
Pot stocks jump as U.S. DOJ moves to reclassify cannabis as a less dangerous drug
(Reuters) - Shares of cannabis companies surged on Tuesday afternoon after the U.S. Department of Justice (DoJ) moved to reclassify marijuana as a less dangerous drug. U.S.-listed shares of Cronos Group, Tilray Brands and Canopy Growth rose between...
15h ago
Biden administration takes step to make marijuana use a less serious crime
(Reuters) - The U.S. Department of Justice on Tuesday moved to make marijuana use a less serious crime, a source familiar with the matter said. If finalized, the policy change could potentially be the biggest shift in federal cannabis policy in 40 ...
15h ago
Breast cancer screening should begin at age 40, U.S. panel says
By Amina Niasse NEW YORK (Reuters) - Women at average risk for breast cancer should get screening mammograms every other year starting at age 40, the U.S. Preventive Services Task Force (USPSTF) said on Tuesday, cementing insurance coverage for the...
18h ago
Incyte misses quarterly profit on weak sales of lead drug
(Reuters) - Incyte Corp on Tuesday reported first-quarter profit below Wall Street estimates on weak sales of its blood cancer drug Jakafi, sending its shares down 2.4%. The company is working on strengthening its pipeline to counter competition fr...
19h ago
GE HealthCare misses quarterly revenue estimates on weakness in China market
(Reuters) - GE HealthCare Technologies missed first-quarter revenue estimates on Tuesday, hurt by lower sales in China market and weaker-than-expected demand for its scanning devices, sending its shares tumbling as much as 12% before the bell. The ...
21h ago
Ecolab to sell global surgical unit for $950 million, lifts 2024 profit forecast
(Reuters) - Water solutions company Ecolab said on Tuesday it would sell its global surgical solutions business to private medical supplier Medline for $950 million in cash and raised its full-year profit forecast. The unit made more than $400 mill...
21h ago
Walmart to close 51 US health centers
(Reuters) - Walmart said on Tuesday it plans to close 51 health centers across five states in the U.S., as well as shut virtual care centers, as the company looks to optimize its business operations in the country. "This is a difficult decision, an...
22h ago
Eli Lilly lifts profit view on diabetes and weight-loss drug strength
(Reuters) -Eli Lilly on Tuesday raised its full-year profit forecast, betting on surging demand for its weight-loss treatment Zepbound and type 2 diabetes drug Mounjaro. Shares of the company rose 3.6% premarket. Sky-rocketing demand for Mounjaro and Z...
23h ago
Risk of bird flu spreading to cows outside US, says WHO
GENEVA (Reuters) - A World Health Organization official said on Tuesday there was a risk of H5N1 bird flu virus spreading to cows in other countries beyond the United States through migratory birds. "With the virus carried around the world by migra...
Apr 30, 2024
Japan's Ono Pharma says $2.4 billion Deciphera purchase 'first step' for global expansion
By Rocky Swift TOKYO (Reuters) - Japan's Ono Pharmaceutical Co said on Tuesday its $2.4 billion takeover of Deciphera Pharmaceuticals is a "first step" in expanding in U.S. and European markets. WHY IT'S IMPORTANT With this deal, Ono Pharma joins J...
Apr 30, 2024
Sandoz reaches agreement with Amgen over patent dispute
ZURICH (Reuters) - Swiss generic and biosimilar manufacturer Sandoz said on Tuesday it had reached an agreement with U.S. drugmaker Amgen resolving all patent litigation related to its U.S. denosumab biosimilars. The agreement clears the way for th...
Apr 30, 2024
Australian regulator weighs India spice mix issue for possible recall
By Rishika Sadam and Aditya Kalra HYDERABAD/NEW DELHI (Reuters) - Australia's food safety agency said on Tuesday it was weighing accusations of contamination about some spice mixes sold by Indian companies MDH and Everest to decide if a food recal...
Apr 30, 2024
J&J, Bristol Myers lose challenges to US drug price negotiation program
By Brendan Pierson (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medi...
Apr 29, 2024
UnitedHealth hackers took advantage of Citrix vulnerabilty to break in, CEO says
By Zeba Siddiqui SAN FRANCISCO (Reuters) - Hackers broke into UnitedHealth's tech unit on Feb. 12 by exploiting a security vulnerability in software from private IT company Citrix that allows employees remote access to their desktop computers, the ...
Apr 29, 2024
US FDA grants full approval for Pfizer's cervical cancer drug
(Reuters) - The U.S. Food and Drug Administration granted traditional approval for Pfizer's drug for cervical cancer patients with disease progression on or after chemotherapy, the agency said on Monday. (Reporting by Pratik Jain in Bengaluru; Edi...
Apr 29, 2024
State health plans must cover gender-affirming surgery, US appeals court rules
By Brendan Pierson (Reuters) - Health insurance plans run by U.S. states must cover gender-affirming surgeries for transgender people, a U.S. appeals court ruled on Monday. The 8-6 opinion from the Richmond, Virginia-based 4th U.S. Circuit Court of...
Apr 29, 2024
USDA to test ground beef in US states with outbreaks of bird flu in dairy cows
By Tom Polansek CHICAGO (Reuters) - The U.S. Department of Agriculture said on Monday it is collecting samples of ground beef in states with outbreaks of bird flu in dairy cows for testing but remains confident the meat supply is safe. The USDA wil...
Apr 29, 2024
One dose of Novo Nordisk's Wegovy back in supply, FDA website shows
(Reuters) - The U.S. Food and Drug Administration website showed on Monday one dose of Novo Nordisk's weight-loss drug Wegovy is available after being in short supply, while three other doses remained in limited availability due to increased demand...
Apr 29, 2024